#162438

Anti-CAR Whitlow Linker [1H5b]

Cat. #162438

Anti-CAR Whitlow Linker [1H5b]

Cat. #: 162438

Unit size: 1 mg

Target: Chimeric antigen receptor Whitlow scFv peptide linker

Class: Monoclonal

Application: Flow cytometry

Host: Mouse

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Erik Kimble, Jocelyn Wright

Institute: Fred Hutchinson Cancer Center

Primary Citation: Kimble et al. 2025.J Immunother Cancer. 2025 Nov 18;13(11):e013123. PMID: 41253497

Tool Details
Target Details
Applications
Handling

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-CAR Whitlow Linker [1H5b]
  • Clone: 1H5B
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Host: Mouse
  • Application: Flow cytometry
  • Description: The anti‑CAR Whitlow linker peptide 1H5b clone is a murine monoclonal antibody that detects cells expressing Whitlow linker‑containing CARs with different antigen specificities, including those harbouring the FMC63‑derived anti‑CD19 scFv as well as other scFvs such as those targeting CD33. It has a mean KD of approximately 0.10 µM for FMC63‑Whitlow scFv protein and 0.11 µM for the Whitlow peptide, with no observable binding to the G4S4 peptide. In flow cytometry, 1H5b stains engineered T cells expressing FMC63‑ or 1H7‑Whitlow CARs, but not the corresponding FMC63‑ or 1H7‑G4S CARs.
  • Immunogen: Synthetic Whitlow peptide
  • Isotype: IgG1

Target Details

  • Target: Chimeric antigen receptor Whitlow scFv peptide linker
  • Target background: While CAR T-cell therapies have revolutionized the treatment of B-lineage malignancies, high-resolution tracking of CAR-engineered cells within the tumor microenvironment (TME) remains a significant technical challenge, particularly in archival formalin-fixed paraffin-embedded (FFPE) tissues. To address this, murine monoclonal antibodies (mAbs) have been developed to specifically target the Whitlow linker, a synthetic peptide commonly utilized in the scFv domains of multiple FDA-approved CAR products (e.g., axi-cel, liso-cel). Because this linker is absent in native human tissue and conserved across various antigen specificities, these mAbs provide a universal tool for the in situ identification, selection, and functional analysis of CAR-expressing cells. This methodology enables a more precise evaluation of CAR T-cell infiltration, persistence, and correlation with clinical outcomes or toxicities.

Applications

  • Application: Flow cytometry

Handling

  • Unit size: 1 mg

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.